These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 32604412

  • 21. Metformin may reduce oral cancer risk in patients with type 2 diabetes.
    Tseng CH.
    Oncotarget; 2016 Jan 12; 7(2):2000-8. PubMed ID: 26683519
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Chronic Metformin Therapy is Associated with a Lower Risk of Hemorrhoid in Patients with Type 2 Diabetes Mellitus.
    Tseng CH.
    Front Pharmacol; 2020 Jan 12; 11():578831. PubMed ID: 33664665
    [Abstract] [Full Text] [Related]

  • 25. Metformin and risk of gingival/periodontal diseases in diabetes patients: A retrospective cohort study.
    Tseng CH.
    Front Endocrinol (Lausanne); 2022 Jan 12; 13():1036885. PubMed ID: 36277720
    [Abstract] [Full Text] [Related]

  • 26. Metformin and endometrial cancer risk in Chinese women with type 2 diabetes mellitus in Taiwan.
    Tseng CH.
    Gynecol Oncol; 2015 Jul 12; 138(1):147-53. PubMed ID: 25913129
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Metformin and the Risk of Dementia in Type 2 Diabetes Patients.
    Chin-Hsiao T.
    Aging Dis; 2019 Feb 12; 10(1):37-48. PubMed ID: 30705766
    [Abstract] [Full Text] [Related]

  • 29. Metformin use is associated with a lower risk of uterine leiomyoma in female type 2 diabetes patients.
    Tseng CH.
    Ther Adv Endocrinol Metab; 2019 Feb 12; 10():2042018819895159. PubMed ID: 31897287
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Metformin may reduce breast cancer risk in Taiwanese women with type 2 diabetes.
    Tseng CH.
    Breast Cancer Res Treat; 2014 Jun 12; 145(3):785-90. PubMed ID: 24816805
    [Abstract] [Full Text] [Related]

  • 33. Pioglitazone and breast cancer risk in female patients with type 2 diabetes mellitus: a retrospective cohort analysis.
    Tseng CH.
    BMC Cancer; 2022 May 18; 22(1):559. PubMed ID: 35585577
    [Abstract] [Full Text] [Related]

  • 34. Metformin Reduces the Risk of Hearing Loss: A Retrospective Cohort Study.
    Tseng CH.
    Otolaryngol Head Neck Surg; 2023 Jun 18; 168(6):1389-1400. PubMed ID: 36939574
    [Abstract] [Full Text] [Related]

  • 35. Rosiglitazone reduces breast cancer risk in Taiwanese female patients with type 2 diabetes mellitus.
    Tseng CH.
    Oncotarget; 2017 Jan 10; 8(2):3042-3048. PubMed ID: 27936468
    [Abstract] [Full Text] [Related]

  • 36. Metformin Decreases Risk of Tuberculosis Infection in Type 2 Diabetes Patients.
    Tseng CH.
    J Clin Med; 2018 Sep 09; 7(9):. PubMed ID: 30205606
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.